These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 10368647

  • 1. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
    Mori S, Murakami-Mori K, Bonavida B.
    Anticancer Res; 1999; 19(2A):1011-5. PubMed ID: 10368647
    [Abstract] [Full Text] [Related]

  • 2. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K, Taga T, Kishimoto T, Nakamura S.
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [Abstract] [Full Text] [Related]

  • 3. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J, Spence MJ, Wallace PM, Forcier K, Hellström I, Vestal RE.
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [Abstract] [Full Text] [Related]

  • 4. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
    Savarese TM, Campbell CL, McQuain C, Mitchell K, Guardiani R, Quesenberry PJ, Nelson BE.
    Cytokine; 2002 Mar 21; 17(6):324-34. PubMed ID: 12061840
    [Abstract] [Full Text] [Related]

  • 5. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
    Liu J, Hadjokas N, Mosley B, Estrov Z, Spence MJ, Vestal RE.
    Cytokine; 1998 Apr 21; 10(4):295-302. PubMed ID: 9617575
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmüller U, Nakajima K, Hirano T, Horn F, Behrmann I.
    Oncogene; 1999 Jun 24; 18(25):3742-53. PubMed ID: 10391682
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M, Ricote M, Parsons MS, García-Tuñón I, Paniagua R, de Miguel MP.
    J Pathol; 2004 Jan 24; 202(1):41-9. PubMed ID: 14694520
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
    Murakami-Mori K, Mori S, Taga T, Kishimoto T, Nakamura S.
    J Immunol; 1997 Jun 01; 158(11):5518-26. PubMed ID: 9164976
    [Abstract] [Full Text] [Related]

  • 9. A selective switch-on system for self-renewal of embryonic stem cells using chimeric cytokine receptors.
    Nakamura T, Arai T, Takagi M, Sawada T, Matsuda T, Yokota T, Heike T.
    Biochem Biophys Res Commun; 1998 Jul 09; 248(1):22-7. PubMed ID: 9675079
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
    Godoy-Tundidor S, Cavarretta IT, Fuchs D, Fiechtl M, Steiner H, Friedbichler K, Bartsch G, Hobisch A, Culig Z.
    Prostate; 2005 Jul 01; 64(2):209-16. PubMed ID: 15712220
    [Abstract] [Full Text] [Related]

  • 11. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity.
    Borsellino N, Bonavida B, Ciliberto G, Toniatti C, Travali S, D'Alessandro N.
    Cancer; 1999 Jan 01; 85(1):134-44. PubMed ID: 9921985
    [Abstract] [Full Text] [Related]

  • 12. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
    Aasland D, Oppmann B, Grötzinger J, Rose-John S, Kallen KJ.
    J Mol Biol; 2002 Jan 25; 315(4):637-46. PubMed ID: 11812136
    [Abstract] [Full Text] [Related]

  • 13. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L, Liu F, Vernallis AB, Aubin JE.
    J Cell Physiol; 2005 Aug 25; 204(2):585-93. PubMed ID: 15751050
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
    Campbell CL, Jiang Z, Savarese DM, Savarese TM.
    Am J Pathol; 2001 Jan 25; 158(1):25-32. PubMed ID: 11141475
    [Abstract] [Full Text] [Related]

  • 15. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
    Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R.
    Cancer Res; 2002 Nov 15; 62(22):6659-66. PubMed ID: 12438264
    [Abstract] [Full Text] [Related]

  • 16. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM, Koch HU, Marschalek R, Schrauzer T, Anders M, Adams E, Fahlbusch R.
    J Neurosurg; 1998 Mar 15; 88(3):541-8. PubMed ID: 9488310
    [Abstract] [Full Text] [Related]

  • 17. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 Mar 15; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 18. Establishment of SSEA-1- and Oct-4-expressing rat embryonic stem-like cell lines and effects of cytokines of the IL-6 family on clonal growth.
    Vassilieva S, Guan K, Pich U, Wobus AM.
    Exp Cell Res; 2000 Aug 01; 258(2):361-73. PubMed ID: 10896787
    [Abstract] [Full Text] [Related]

  • 19. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F, Kinzie E, Wang Y, Duplomb L, Godard A, Held WA, Asch BB, Baumann H.
    Oncogene; 2002 Sep 12; 21(41):6264-77. PubMed ID: 12214267
    [Abstract] [Full Text] [Related]

  • 20. Differential expression and effects of gp130 cytokines and receptors in prostate cancer cells.
    Palmer J, Hertzog PJ, Hammacher A.
    Int J Biochem Cell Biol; 2004 Nov 12; 36(11):2258-69. PubMed ID: 15313471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.